<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04955054</url>
  </required_header>
  <id_info>
    <org_study_id>M2020362</org_study_id>
    <nct_id>NCT04955054</nct_id>
  </id_info>
  <brief_title>the Association of Intestinal Microbial Metabolites and Cardiac Function in Acute Myocardial Infarction</brief_title>
  <official_title>the Association of Intestinal Microbial Metabolites and Cardiac Function in Acute Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University Third Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recently, more and more studies have confirmed that intestinal flora is closely related to&#xD;
      the occurrence and development of cardiovascular diseases.Bile acids (BAS), short chain fatty&#xD;
      acids (SCFA) and trimethylamine oxide (TMAO), the main metabolites of intestinal flora, are&#xD;
      the key mediators of the interaction between gut and host. We aim to explore the association&#xD;
      of BAs and SCFA with cardiac function in patients with AMI.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiovascular disease is the leading cause of death in China, and acute myocardial&#xD;
      infarction (AMI) is the main cause of death of cardiovascular disease. In recent years,&#xD;
      clinical epidemiological studies have confirmed that intestinal flora is closely related to&#xD;
      the occurrence and development of cardiovascular diseases such as diabetes, hyperlipidemia,&#xD;
      hypertension, atherosclerosis, coronary heart disease, heart failure and so on. Bile acids&#xD;
      (BAS), short chain fatty acids (SCFA) and trimethylamine oxide (TMAO), the main metabolites&#xD;
      of intestinal flora, are the key mediators of the interaction between gut and host. It is&#xD;
      suggested that intestinal flora and its metabolites participate in the pathophysiological&#xD;
      process of cardiovascular disease through inflammation, oxidative stress and programmed&#xD;
      death, and have the potential to be intervention targets. Basic and clinical studies have&#xD;
      shown that TMAO is associated with the onset and poor prognosis of AMI by promoting the&#xD;
      development of atherosclerosis and thrombosis, but there are few reports on the relationship&#xD;
      between BAs or SCFA and AMI. We aim to explore the association of BAs and SCFA with cardiac&#xD;
      function in patients with AMI.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 11, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">October 11, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the plasma levels of BAs and SCFA</measure>
    <time_frame>one week</time_frame>
    <description>the plasma levels of bile acids and short chain fatty acid in fast</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <description>patients without coronary artery disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>UAP</arm_group_label>
    <description>patients without unstable angina pectoris</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AMI</arm_group_label>
    <description>patients with acute myocardial infarction</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>diagnose</intervention_name>
    <description>Patients from UAP and AMI meet the criteria of UAP or STEMI.</description>
    <arm_group_label>AMI</arm_group_label>
    <arm_group_label>UAP</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The patient, aged 18-85 years, had undergone coronary angiography and agreed to be enrolled&#xD;
        and signed the informed consent. And they met the inclusion criteria and did not meet the&#xD;
        exclusion criteria.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        The patient, aged 18-85 years, had undergone coronary angiography and agreed to be enrolled&#xD;
        and signed the informed consent.&#xD;
&#xD;
        AMI : according to ST segment elevation myocardial infarction diagnostic criteria.&#xD;
&#xD;
        UAP:&#xD;
&#xD;
          1. typical chest pain symptoms;&#xD;
&#xD;
          2. negative in markers of myocardial injury;&#xD;
&#xD;
          3. The stenosis of main coronary artery or its main branches is more than 50%&#xD;
&#xD;
        Control:&#xD;
&#xD;
          1. atypical chest pain symptoms&#xD;
&#xD;
          2. negative in markers of myocardial injury;&#xD;
&#xD;
          3. The stenosis of main coronary artery and its main branches is less than 50%&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Acute infection or application of antibiotics in the past 3 months;&#xD;
&#xD;
          2. Chronic heart failure;&#xD;
&#xD;
          3. History of inflammatory or absorptive bowel disease and bowel resection;&#xD;
&#xD;
          4. Acute, chronic liver disease or other reasons lead to abnormal liver function&#xD;
             (transaminase is more than 5 times of normal value);&#xD;
&#xD;
          5. Renal insufficiency (serum creatinine &gt; 220Î¼ml/L or creatinine clearance rate &lt; 30&#xD;
             ml/min);&#xD;
&#xD;
          6. Malignant tumor;&#xD;
&#xD;
          7. Autoimmune diseases;&#xD;
&#xD;
          8. Uninformed patients&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Peking University Third Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100191</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guisong Wang, doctor</last_name>
      <phone>13701070359</phone>
      <email>guisongwang@bjmu.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Yunxiao Zhang, doctor</last_name>
      <phone>18811333108</phone>
      <email>Zhang_doc@126.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 29, 2021</study_first_submitted>
  <study_first_submitted_qc>June 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 8, 2021</study_first_posted>
  <last_update_submitted>June 29, 2021</last_update_submitted>
  <last_update_submitted_qc>June 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>bile acids</keyword>
  <keyword>short chain fatty acid</keyword>
  <keyword>cardiac function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

